Candela's New GentleYAG Laser Receives FDA Clearance; Revolutionary Hair Removal Laser Ideal for Darker Skin Types.
From: Business Wire
Business Editors and Health/Medical Writers
WAYLAND, Mass.--(BW HealthWire)--April 19, 2001
Candela Corporation (NASDAQ:CLZR) announced today that its new GentleYAG(TM) Nd:YAG long pulse laser has received FDA clearance for hair reduction and the treatment of vascular lesions. The GentleYAG facilitates hair removal in darker skinned patients, including skin types V and VI.
Gerard E. Puorro, Candela's President and CEO, commented: "FDA clearance for the GentleYAG laser is very significant for the laser hair removal market. This is our first laser that completely meets ...
About Our Articles: We've partnered with Highbeam Research to provide these article excerpts for your research needs. However, due to copyright laws, we cannot publish the whole article. To view these articles in full length you'll need to use the link above to access the free trial at Highbeam.